Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 25;33(1):70–75. doi: 10.1016/j.pnpbp.2008.10.005

Figure 3.

Figure 3

Amounts of NR1, NR2A, NR2B, and PSD-95 immunoreactivities in the anterior PFC from control subjects (open bars; n=13–14) and depressed subjects (filled bars; n=13–14). Significant reductions in the NR2A, NR2B, and PSD-95 immunoreactivities were observed in depressed subjects as compared to controls; * p<0.05; **p<0.01.